Speaker illustration

Ms Magdalena Kopytek

John Paul II Hospital, Krakow (Poland)

Non-vitamin K antagonist oral anticoagulants (NOACs) attenuate valvular calcification in patients with severe aortic stenosis

Event: ESC Congress 2022

Topic: Valvular Heart Disease

Session: Pathomechanisms and treatment of valve disease

Thumbnail

Rivaroxaban attenuates valvular inflammation and tissue remodeling in patients with severe aortic stenosis

Event: ESC Congress 2021 - The Digital Experience

Topic: Aortic Valve Stenosis

Session: Valvular heart disease and infective endocarditis e-posters

Thumbnail

An association of low-density lipoproteins and fibrinolysis in patients with severe aortic stenosis- valvular expression of fibrinolytic proteins

Event: ESC Congress 2021 - The Digital Experience

Topic: Aortic Valve Stenosis

Session: Valvular heart disease and infective endocarditis e-posters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk